Lombard Medical Inc
OTC:EVARF
Lombard Medical Inc
OTC:EVARF
Price:
0.0001
USD
Market Closed
Market Cap:
$28
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Lombard Medical Inc
OTC:EVARF
|
UK |
|
Pharmaust Ltd
ASX:PAA
|
AU |
|
Adcock Ingram Holdings Ltd
OTC:AIHLF
|
ZA |
|
C
|
China Financial International Investments Ltd
HKEX:721
|
HK |
|
S
|
SecondXight Analytica Inc
TSE:5028
|
JP |
|
Deutsche Post AG
XETRA:DHL
|
DE |
Cash Flow Statement
Cash Flow Statement
Lombard Medical Inc
Lombard Medical Inc
Currency: USD
| Sep-2013 | Dec-2013 | Jun-2014 | Sep-2014 | Dec-2014 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||
| Net Income |
(20)
|
(20)
|
(31)
|
(34)
|
(36)
|
(36)
|
(37)
|
(40)
|
(48)
|
(38)
|
(36)
|
(33)
|
|
| Depreciation & Amortization |
1
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
2
|
2
|
2
|
2
|
|
| Other Non-Cash Items |
1
|
1
|
4
|
4
|
2
|
1
|
2
|
4
|
5
|
5
|
4
|
8
|
|
| Cash Taxes Paid |
(1)
|
0
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(3)
|
0
|
(2)
|
(2)
|
0
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
2
|
1
|
|
| Change in Working Capital |
3
|
1
|
(2)
|
(1)
|
(2)
|
1
|
(3)
|
1
|
(1)
|
(5)
|
(1)
|
(3)
|
|
| Cash from Operating Activities |
(16)
N/A
|
(18)
-13%
|
(28)
-58%
|
(30)
-7%
|
(34)
-15%
|
(33)
+5%
|
(36)
-10%
|
(34)
+6%
|
(42)
-25%
|
(37)
+14%
|
(31)
+16%
|
(25)
+18%
|
|
| Investing Cash Flow | |||||||||||||
| Capital Expenditures |
(1)
|
(4)
|
(4)
|
(4)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
|
| Other Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
0
|
0
|
|
| Cash from Investing Activities |
(1)
N/A
|
(4)
-191%
|
(4)
-20%
|
(4)
+3%
|
(2)
+64%
|
(1)
+39%
|
(1)
-2%
|
(1)
-39%
|
(2)
-14%
|
(1)
+49%
|
(0)
+61%
|
(0)
+70%
|
|
| Financing Cash Flow | |||||||||||||
| Net Issuance of Common Stock |
55
|
55
|
55
|
55
|
55
|
0
|
0
|
0
|
0
|
0
|
0
|
5
|
|
| Net Issuance of Debt |
3
|
3
|
0
|
0
|
0
|
11
|
11
|
16
|
0
|
5
|
7
|
12
|
|
| Other |
(2)
|
(2)
|
(7)
|
(7)
|
(5)
|
1
|
1
|
(1)
|
(2)
|
(1)
|
(2)
|
(2)
|
|
| Cash from Financing Activities |
56
N/A
|
56
0%
|
48
-13%
|
48
+0%
|
50
+3%
|
12
-76%
|
12
-1%
|
15
+22%
|
14
-3%
|
3
-77%
|
5
+67%
|
16
+197%
|
|
| Change in Cash | |||||||||||||
| Effect of Foreign Exchange Rates |
2
|
2
|
5
|
(1)
|
(1)
|
(3)
|
0
|
(0)
|
(1)
|
(1)
|
(1)
|
(2)
|
|
| Net Change in Cash |
41
N/A
|
36
-11%
|
21
-44%
|
13
-38%
|
12
-2%
|
(24)
N/A
|
(25)
-3%
|
(21)
+16%
|
(31)
-47%
|
(35)
-14%
|
(27)
+24%
|
(12)
+57%
|
|
| Free Cash Flow | |||||||||||||
| Free Cash Flow |
(17)
N/A
|
(22)
-27%
|
(33)
-50%
|
(34)
-5%
|
(36)
-5%
|
(34)
+6%
|
(37)
-9%
|
(35)
+5%
|
(44)
-25%
|
(37)
+15%
|
(31)
+16%
|
(25)
+18%
|
|
Switch to:
Switch to:
See Also
Discover More
